Kura Oncology, Inc. (NASDAQ:KURA) Receives Consensus Recommendation of “Moderate Buy” from Analysts
Shares of Kura Oncology, Inc. (NASDAQ:KURA – Get Free Report) have received an average rating of “Moderate Buy” from the thirteen ratings firms that are covering the firm, Marketbeat.com reports. Three investment analysts have rated the stock with a hold recommendation, eight have given a buy recommendation and two have given a strong buy recommendation […]
Shares of Kura Oncology, Inc. (NASDAQ:KURA – Get Free Report) have received an average rating of “Moderate Buy” from the thirteen ratings firms that are covering the firm, Marketbeat.com reports. Three investment analysts have rated the stock with a hold recommendation, eight have given a buy recommendation and two have given a strong buy recommendation […]
